1. Idiosyncratic liver injury induced by bolus combination treatment with emodin and 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucopyranoside in rats
   Dan Li et al, 2022, Frontiers in Pharmacology CrossRef
2. Medicinal plants cultivated in Egypt with anticancer potential; a systematic review
   Iman Abdelhady Elshnoudy et al, 2024, Phytochemistry Reviews CrossRef
3. Therapeutic Potential of Emodin for Gastrointestinal Cancers
   Sierra J. McDonald et al, 2022, Integrative Cancer Therapies CrossRef
4. Long non‑coding RNA RP11‑81H3.2 suppresses apoptosis by targeting microRNA‑1539/COL2A1 in human nucleus pulposus cells
   Lin Qiao et al, 2021, Experimental and Therapeutic Medicine CrossRef
5. Isoliquiritigenin attenuates emodin-induced hepatotoxicity in vivo and in vitro through Nrf2 pathway
   Boran Ni et al, 2022, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology CrossRef
6. Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer
   Yuan Gao et al, 2024, Current Cancer Drug Targets CrossRef